In atherosclerosis and endothelial dysfunction, activation of LOX-1 stimulates the NF-κB signaling pathway to promote the expression of proinflammatory cytokines, such as IL-1b, TNF-α, MCP1, IL-8, and IL-6 [58]. Here, NFKB1 is linked to atherosclerosis.